NEW YORK, NY — As the world enters the second week of Breast Cancer Awareness Month, a global movement is preparing to shift the narrative from "early detection" to the stark reality of those living with the most advanced form of the disease. On October 13, 2026, National Metastatic Breast Cancer Awareness Day, the #LightUpMBC campaign will orchestrate a massive display of solidarity, illuminating more than 325 iconic landmarks across 50 U.S. states and 20 countries.
From the spire of One World Trade Center in Manhattan to the mist of Niagara Falls and the terminals of Mactan-Cebu Airport in the Philippines, the world will be bathed in teal, green, and pink. This annual event, organized by METAvivor Research and Support, aims to illuminate the often-overlooked plight of metastatic breast cancer (MBC) patients, honoring those lost to the disease while raising critical funds for life-extending research.
Main Facts: A Global Call to Action for Stage 4 Research
Metastatic breast cancer, also known as Stage 4, remains a terminal diagnosis with no known cure. While traditional "Pinktober" campaigns focus heavily on mammograms and "winning the fight," METAvivor and the #LightUpMBC initiative seek to highlight the 100% of breast cancer deaths that occur once the disease has metastasized.
The Scope of the 2026 Campaign
The 2026 iteration of #LightUpMBC marks the largest activation in the campaign’s history. Landmarks in 195 cities will participate, creating a literal and figurative "trail of light" across the globe. Key participating sites include:
- The United States: Willis Tower (Chicago), Philadelphia City Hall, and the Memorial Bridge (Portsmouth, NH).
- International: Ness Bridge (Inverness, Scotland) and various sites across Europe and Asia.
The campaign culminates in #LightUpMBC Live, a free virtual broadcast streaming at 8 p.m. ET / 5 p.m. PT. Hosted by Tami Eagle Bowling and Broadway star Kara Lindsay, the program serves as a bridge between the scientific community and the patient population, featuring musical performances and live dispatches from illuminated landmarks.
The Financial Mission
Unlike many breast cancer organizations that split funds between awareness, early detection, and support services, METAvivor has a singular mandate: 100% of net proceeds from #LightUpMBC are directed toward Stage 4 metastatic breast cancer research. The organization utilizes a rigorous peer-review process involving both scientific experts and patient advocates to ensure that the most promising, life-extending projects receive funding.
Chronology: From a Single Bridge to a Global Phenomenon
The evolution of #LightUpMBC is a testament to the power of grassroots advocacy and the enduring legacy of a single patient.
2013–2016: The Roots of Advocacy
In 2013, Dr. Kelly Shanahan was diagnosed with MBC, joining a community of patients who felt sidelined by mainstream awareness campaigns. During this period, the metastatic community began to organize more formally, pushing for a distinction between early-stage survivorship and the lifelong treatment required for Stage 4.
2017: The First Light
The #LightUpMBC campaign was inspired by Jessica Moore, a young woman diagnosed with MBC who passed away at the age of 36. Her wish was simple: to see one local landmark lit in the colors of metastatic awareness to acknowledge those for whom "pink" wasn’t enough. In 2017, the Memorial Bridge in Portsmouth, New Hampshire, became the first landmark to light up, sparking a movement led by Moore’s best friend, Laura Inahara.
2018–2025: Exponential Growth
What began as a single bridge quickly scaled to dozens, then hundreds of locations. The campaign introduced the #LightUpMBC Live stream during the COVID-19 pandemic to maintain momentum when in-person gatherings were restricted. By 2025, the campaign had raised over $2.7 million for research, establishing itself as a primary pillar of METAvivor’s annual fundraising.
2026: A Global Milestone
The current campaign represents a peak in international cooperation. With 20 countries participating, the movement has transcended national borders, reflecting the universal nature of the disease and the global need for a cure.
Supporting Data: The Stark Reality of MBC in 2026
To understand the urgency behind #LightUpMBC, one must look at the epidemiological data surrounding breast cancer in the United States and globally.
Mortality and Diagnosis
According to data from the National Cancer Institute’s SEER program, approximately 42,670 people in the U.S. are expected to die from breast cancer in 2026. This equates to roughly 117 deaths every single day.
- Initial Diagnosis: A significant percentage of patients are "de novo" metastatic, meaning they are diagnosed at Stage 4 from the very beginning.
- Recurrence: For others, MBC appears years or even decades after they were told they were "cancer-free" following treatment for early-stage disease.
- The Site of Death: It is a medical fact that patients do not die from cancer contained within the breast. Mortality occurs when the cancer spreads to vital organs—most commonly the bones, liver, lungs, or brain.
The Funding Gap
Historically, only an estimated 2% to 5% of overall breast cancer research funding is dedicated to metastatic disease. The #LightUpMBC campaign seeks to correct this imbalance. By funneling 100% of donations into Stage 4 research, METAvivor addresses the specific biological mechanisms of metastasis, which differ significantly from the mechanisms of primary tumor growth.
The Symbolism of Color
The choice of teal, green, and pink is intentional and symbolic:
- Teal: Represents healing and spirituality.
- Green: Symbolizes the triumph of spring over winter, representing life and renewal.
- Pink: Acknowledges that the cancer originated in the breast.
Official Responses: Voices from the Front Lines
The leadership of METAvivor and the creators of the campaign emphasize that while the lights are beautiful, the purpose is profoundly serious.
Dr. Kelly Shanahan, METAvivor Board President, reflected on her own journey and the role of research. "When I was diagnosed with metastatic breast cancer in 2013, I certainly didn’t think I’d still be here 13 years later," she said. "My hope and the hope of so many others lies in research, and METAvivor-funded research is increasingly important these days. #LightUpMBC is the biggest contributor to this research and is also a way to bring us together as a community."
Laura Inahara, Founder of #LightUpMBC, spoke to the legacy of the campaign’s inspiration. "My best friend and the inspiration behind this campaign, Jessica Moore, died of metastatic breast cancer at just 36. Jessica hoped to illuminate one local landmark. Today, her legacy helps families around the world shine a light for the people they love, teach patients with MBC how to advocate for themselves, and has now raised over $2.7 million for critical MBC research."
Tami Eagle Bowling, Campaign Director and Livestream Host, highlighted the dual nature of the event as both a fundraiser and a beacon of hope. Bowling, who has lived with MBC for 11 years, noted that the program is designed to "meet the people behind the lights," giving a face to the statistics.
Implications: Changing the Future of Oncology
The #LightUpMBC campaign has implications that reach far beyond a single night of colored lights. It is driving a fundamental shift in how the public, the medical community, and the pharmaceutical industry approach breast cancer.
From Terminal to Chronic
The ultimate goal of METAvivor is to transition MBC from a terminal disease into a survivable, chronic condition. By funding research into treatment resistance and the molecular drivers of metastasis, the campaign is helping to extend the "quality of life" for thousands. As more patients live longer with Stage 4 disease, the demand for "survivorship" resources tailored to those in permanent treatment is growing.
Patient-Led Research
METAvivor’s model of including patient advocates in the grant review process is a significant shift in scientific philanthropy. It ensures that research is not just scientifically sound but also "patient-centric," focusing on outcomes that matter most to those living with the disease, such as reducing toxicity and maintaining cognitive function during treatment.
Redefining Awareness Month
The success of #LightUpMBC is forcing a re-evaluation of Breast Cancer Awareness Month. There is a growing movement to move "Beyond the Pink," demanding that awareness must include the reality of those who will never "finish" treatment. This shift is crucial for policy changes, including social security disability reform and increased federal funding for metastatic research.
Global Solidarity
As landmarks in the Philippines, Scotland, and Canada join U.S. cities, the campaign fosters a global network of patients and researchers. This international pressure can lead to faster cross-border clinical trials and more equitable access to new therapies worldwide.
How to Participate
The public is encouraged to visit www.lightupmbc.org to find a map of participating landmarks. Supporters can join the movement by:
- Photography: Capturing images of illuminated landmarks and sharing them on social media with the hashtags #LightUpMBC and #METAvivor.
- Viewing: Tuning into the #LightUpMBC Live stream on October 13 at 8 p.m. ET via YouTube, Facebook, or LiveOne.
- Donating: Contributing directly to research funds, knowing that 100% of net proceeds go to Stage 4 grants.
As October 13 approaches, the message from the metastatic community is clear: awareness is the first step, but research is the only way to turn the lights of hope into a reality of survival.
About the Author
